Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The semaglutide group showed a significantly improved Kansas City Cardiomyopathy Questionnaire clinical summary score and a longer 6-min walking distance from baseline (21.5 m and 1.2 m in the semaglutide and placebo groups, respectively, intergroup difference 20.3 m, 95% CI 8.632.1 m), compared with that in the placebo group despite the relatively short observation period of 52 weeks
However, human biology differs significantly
The result is more consistent IGF-1 elevation, more pronounced body composition changes at the 3-month mark, and better long-term anti-aging outcomes
C., Salinas, A., Melloni, R
US$ 23.84
US$ 25.23
US$ 26.73
US$ 21.50
